Gene Panel Market to be Dominated by Amplicon-Based Approach Technique Through 2028
Increasing incidence of cancer is expected to drive the
growth of global gene panel in the forecast period 2024-2028.
According to TechSci Research report, “Gene Panel Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”,
the global gene panel market is
anticipated to grow at an impressive rate in the forecast period, 2024-2028.
This can be ascribed to the increasing technological advancements in
genomics such as NGS technology and increasing adoption rate of genetic
testing. Additionally, growing demand for prenatal diagnosis and increasing
awareness about advantages of using gene panel technique, instead of
conventional method, is expected to create lucrative opportunities for the
market growth in coming years. Besides, growing initiatives in population
sequencing by the government and rising investments by major key players to
develop a new technology, are further expected to support the market growth.
However, inability
of next generation sequencing gene panels in detecting some allelic mutations
and growing concerns about genetic data security, lack of accuracy and
standardization in diagnostic tests may hamper the market growth.
Browse over XX market data Figures
spread through XX
Pages and an in-depth TOC on "Gene Panel Market"
The Global Gene Panel Market can be segmented by component, by
technique, by design, by application, by end user and by region.
Based on component, the global gene panel market
can be divided into Test Kits and Testing Services.
The test kit segment is expected to dominate the market in 2022 and is expected
to continue maintaining its dominance throughout the forecast period. The increasing need for gene panel kit for
research and development activities and diagnostics center (because of rising
prevalence of different infectious and genetic diseases), are some of the
factors supporting the segmental growth. Based on technique, the global gene panel
market can be divided into Amplicon Based Approach and Hybridization Based
Approach. The amplicon-based approach segment is dominated the market in 2022
and is expected to continue maintaining its dominance throughout the forecast
period. Increasing demand for amplicon-based approach because of its high
target rates and requirement of short time for sequencing in comparison to
hybridization is expected to drive the segmental growth.
In terms of application, the global gene panel market
can be categorized into Cancer Risk Assessment, Diagnosis of Congenital Diseases,
Pharmacogenetics, Others. The cancer
risk assessment segment is dominated the market in 2022 on account of rising
incidence of cancer across the globe and the minimally invasive nature of gene
panels. According to reports, in 2022, there will be an estimated 1.9
million new cancer cases diagnosed and 609,360 cancer deaths in the United
States.
Major companies operating in global gene panel market are:
- Illumina, Inc.
- Agilent Technologies, Inc.
- Thermo Fischer Scientific,
Inc.
- QIAGEN NV
- Eurofins Scientific SE
- Foundation Medicine Inc.
- Guardant Health, Inc.
- Myriad Genetic Laboratories
Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
Various companies operating in the market are adopting strategies such
as mergers & acquisitions, product launches, among others in order to stay
competitive and have an edge over other players operating in the market. Many
companies have started making heavy investments in their research &
development activities in order to improvise the existing product portfolio and
also develop advanced products.
Customers can also request
for 10% free customization on this report.
“The Asia
Pacific is expected to dominate and register the highest growth in the global gene
panel market on account of increasing demand for safe and effective genetic
tests in the region. Furthermore, increasing demand for personalized medicine
is expected to support the market growth in the region in the coming years., In
addition, the growing application of genetic testing in oncology is further
expected to fuel the market growth in the coming years. . Additionally, growing
healthcare spending is one of the major factors responsible for creating
lucrative opportunities for the market growth” said Mr. Karan Chechi, Research
Director with TechSci Research, a research based global management consulting
firm.
“Gene
Panel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
2018-2028F Segmented By Component
(Test Kits v/s Testing Services), By Technique (Amplicon Based Approach v/s
Hybridization Based Approach), By Design (Predesigned Gene Panel v/s Customized
Gene Panel), By Application (Cancer Risk Assessment, Diagnosis of Congenital
Diseases, Pharmacogenetics, Others), By End User (Academic & Research
Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical &
Biotechnology Companies), By
Region and Competition”, has evaluated
the future growth potential of global gene panel market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global gene panel market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com